Macrogenics (MGNX) Misses Q1 EPS by 1c

Macrogenics (NASDAQ: MGNX) reported Q1 EPS of ($0.58), $0.01 worse than the analyst estimate of ($0.57). Revenue for the quarter came in at $20.8 million versus the consensus estimate of $17.04 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.

You May Also Be Interested In

• Aristocrat Leisure (ALL:AU) (ARLUF) PT Raised to AUD66 at RBC Capital
• RBC Capital Starts Innio NV (INIO) at Sector Perform
• Jefferies Upgrades Mercedes-Benz Group (MBG:GR) (DDAIF) to Buy